Effects of the selective acetylcholinesterase inhibitor TAK-802 on the voiding behavior and bladder mass increase in rats with partial bladder outlet obstruction

Journal of Urology

Volumn 174, Issue 3, 2005, Pages 1137-1141

  Hashimoto, Tadatoshi ^a   Nagabukuro, Hiroshi ^a   Doi, Takayuki ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Bladder; bladder neck obstruction; rats; Wistar; cholinesterase inhibitors; urination

Indexed keywords

BETHANECHOL; CHOLINESTERASE INHIBITOR; DISTIGMINE; MUSCARINIC AGENT; TAK 802; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CONTRACTION; BLADDER EMPTYING; BLADDER FUNCTION; BLADDER NECK STENOSIS; CONTROLLED STUDY; DETRUSOR MUSCLE; DRUG EFFECT; MALE; MICTURITION; NONHUMAN; PRIORITY JOURNAL; RAT; RESIDUAL URINE; URINE VOLUME;

EID: 23744484551     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000168616.71956.a4     Document Type: Article

References (19)

1. Javle, P., Jenkins, S. A., West, C. and Parsons, K. F.: Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy. J Urol, 156: 1014, 1996
2. Groutz, A., Gordon, D., Lessing, J. B., Wolman, I., Jaffa, A. and David, M. P.: Prevalence and characteristics of voiding difficulties in women: are subjective symptoms substantiated by objective urodynamic data? Urology, 54: 268, 1999
3. Madjar, S. and Appell, R. A.: Impaired detrusor contractility: anything new? Curr Urol Rep, 3: 373, 2002
4. Wein, A. J., Longhurst, P. A. and Levin, R. M.: Pharmacologic treatment of voiding dysfunction. In: Urodynamics. Principles, Practice and Application, 2nd ed. Edited by A. R. Mundy, T. P. Stephenson and A. J. Wein. New York: Churchill Livingstone, sect. A, chapt. 4, pp. 43-70. 1994
5. King, J. A., Huddart, H. and Staff, W. G.: Effect of choline ester analogues, noradrenaline and nifedipine on normal and hypertrophied human urinary bladder detrusor muscle. Gen Pharmacol, 30: 131, 1998
6. Sibley, G. N.: A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J Physiol, 354: 431, 1984
7. Tanaka, Y., Masumori, N., Itoh, N., Furuya, S., Nishizawa, O. and Tsukamoto, T.: Symptomatic and urodynamic improvement by oral distigmine bromide in poor voiders after transurethral resection of the prostate. Urology, 57: 270, 2001
8. De Wachter, S., Van Meel, T. D. and Wyndaele, J. J.: Study of the afferent nervous system and its evaluation in women with impaired detrusor contractility treated with bethanechol. Urology, 62: 54, 2003
9. Nagabukuro, H., Okanishi, S., Imai, S., Ishichi, Y., Ishihara, Y. and Doi, T.: Effects of TAK-802, a novel acetylcholinesterase inhibitor, on distension-induced rhythmic bladder contractions in rats and guinea pigs. Eur J Pharmacol, 485: 299, 2004
10. Saito, M., Longhurst, P. A., Tammela, T. L., Wein, A. J. and Levin, R. M.: Effects of partial outlet obstruction of the rat urinary bladder on micturition characteristics, DNA synthesis and the contractile response to field stimulation and pharmacological agents. J Urol, 150: 1045, 1993
11. Somogyi, G. T. and de Groat, W. C.: Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladder. J Auton Nerv Syst, 37: 89, 1992
12. Hirotsu, I., Hayano, C. and Tani, T.: Effect of muscarinic agonist on overflow incontinence induced by bilateral pelvic nerve transection in rats. Jpn J Pharmacol, 76: 109, 1998
13. Nagabukuro, H., Okanishi, S. and Doi, T.: Effects of TAK-802, a novel acetylcholinesterase inhibitor, and various cholinomimetics on the urodynamic characteristics in anesthetized guinea pigs. Eur J Pharmacol, 494: 225, 2004
14. Bennett, N., O'Leary, M., Patel, A. S., Xavier, M., Erickson, J. R. and Chancellor, M. B.: Can higher doses of oxybutynin improve efficacy in neurogenic bladder? J Urol, 171: 749, 2004
15. Resnick, N. M. and Yalla, S. V.: Detrusor hyperactivity with impaired contractile function. An unrecognized but common cause of incontinence in elderly patients. JAMA, 257: 3076, 1987
16. Finkbeiner, A. E., Bissada, N. K. and Welch, L. T.: Uropharmacology: v. choline esters and other parasympathomimetic drugs. Urology, 10: 83, 1977
17. Yossepowitch, O., Gillon, G., Baniel, J., Engelstein, D. and Livne, P. M.: The effect of cholinergic enhancement during filling cystometry: can edrophonium chloride be used as a provocative test for overactive bladder? J Urol, 165:1441, 2001
18. Monson, F. C., Sun, L., Wein, A. J. and Levin, R. M.: Hyperplasia in the rabbit bladder urothelium following partial outlet obstruction. Autoradiographic evidence. Mol Cell Biochem, 152: 167, 1995
19. Ohnishi, N., Horan, P., Levin, S. S. and Levin, R. M.: Intermittent catheterization limits rabbit bladder dysfunction in response to partial outlet obstruction. J Urol, 163: 292, 2000